OREANDA-NEWS. February 10, 2012. Investments in the domestic pharmaceutical industry will not only improve the quality of drugs, but the technological level of domestic producers. This was stressed by Minister of Health of Ukraine during the briefing in the Cabinet of Ministers of Ukraine.

"Ministry made some steps to develop and further production vital medicines on the basis of pharmaceutical companies. Creation of own production of the necessary preparations will provide our citizens with quality and moderate medicines"- the Minister of Health said.

According to him attraction of investments in development of domestic pharmaceutical industry not only increases the technological level of domestic manufacturers and quality products, but also enhances their export potential. The Minister gave a number of examples of effective projects in Ukraine. In particular, Oleksandr Anischenko noted fruitful cooperation of American pharmaceutical giant, the company Eli Lilly with the factory Farmak in the production of effective national medicines for diabetes (plant "Farmak" was passed on license technology of full production of recombinant human insulin); investing of Russian brand Pharmstandard in Ukrainian company Biolik (Kharkiv) which specializes in the production of vaccines, and others.
"For example, technology transfers of production of vaccine "Pentaksim" (vaccines for diphtheria, pertussis, tetanus, polio) by "Sanofi Pasteur" (France) to Ukrainian firm "Farmeks Group" (Boryspil, Kiev region) and production by domestic producer of vaccines allowed to reduce the purchase price of the vaccine and thus to provide more people with this immunobiological preparation"- the Minister said.

Oleksandr Anischenko stressed that forming of clear market condition of function for the pharmaceutical sector, based on the European approach, is attractive for investment in pharmaceutical industry of Ukraine and - for the development of domestic pharmaceutical industry, therefore the economy of Ukraine.